KETOTIFEN IN THE TREATMENT OF ALLERGIC CONJUNCTIVITIS



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

About the authors

O G Elisyutina

E A Tsyvkina

E S Fedenko

O G Elisyutina

Institute of Immunology

Institute of Immunology

E A Tsivkina

Institute of Immunology

Institute of Immunology

E S Fedenko

Institute of Immunology

Institute of Immunology

References

  1. Аллергология и иммунология. Национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М., «ГЭОТАР-Медиа», 2009, 656 с.
  2. Friedlander M.H. Current ocular therapy. Ed. F.T. Frannfelder, Roy F.H., Randall J., W.B. Saunders Comp. 2000, p. 323.
  3. Майчук Ю.Ф. Аллергические конъюнктивиты. Рос. мед. журн., 2002, т. 3, № 1, с. 6-10,
  4. Hingorani M., Calder V., Buckley R.J. and Lightman S. The Role of Conjunctival Epithelial Cells in Chronic Ocular Allergic Disease. Exp. Eye Res. 1998, v. 67, p. 491-500.
  5. Клинические рекомендации. Офтальмология. Под ред. Л.К. Мошетовой, А.П. Нестерова, Е.А. Егорова. М., «ГЭ-ОТАР-Медиа», 2008, с. 9-43.
  6. Мачарадзе Д.Ш. Лечение аллергических конъюнктивитов. Леч. Врач. 2008, №4, с. 8-10.
  7. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус Принт», 1998, 252 с.
  8. Schechter B.A. Ketorolac tromethamine 0,4% as a treatment for allergic conjunctivitis. Expert Opin Drug Metab Toxicol. 2008 , v. 4 (4), p. 507-511.
  9. Grant S.M., Goa K.L., Fitton A. et al. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs, 1990, v. 40, p. 412-448.
  10. Nabe M., Miyagawa H., Agrawal D.K. et al. The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. Allergy Proc. 1991, v. 12, p. 267-271.
  11. Miki I., Kusano A., Ohta S. et al. Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell. Immunol. 1996, v. 171, p. 285-288.
  12. Abelson M.B., Chambers W.A., Smith L.M. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch. Ophthalmol., 1990, v. 108., p. 84-88.
  13. Abelson M.B., Chapin M.J., Kapik B.M. et al. Efficacy of ketotifen fumarate 0,025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model. Arch. OphthalmoL. 2003, v. 121, p. 626-630.
  14. Greiner J.V., Mundorf T., Dubiner H. et al. Efficacy and safe W of ketotifen fumarate 0,025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis. Am. J. Ophthalmol. 2003, v. 136, p. 1097-1105.
  15. Crampton H.J. A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0,025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model. Clin. Ther. 2002, v. 24, p. 1800-1808.
  16. Abelson M.B., Ferzola N.J., McWhirter C.L., Crampton H.J. Efficacy and safe W of single- and multiple-dose ketotifen fumarate 0,025% ophthalmic solution in a pediatric population. PediatrAIlergy Immunol. 2004, v. 15, p. 551-557.
  17. Mark B. Abelson, Nancy J. Ferzola, Cecilia L. McWhirter, Henry J. Crampton. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0,025% ophthalmic solution in a pediatric population. Pediatr. Allergy Immunol. 2004, v. 15, p. 551-557.
  18. Kidd M., McKenzie S.H., Steven I. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. Br. J. Ophthalmol. 2003, v. 87, p. 1206-1211.
  19. Horak F., Stubner P., Zieglmayer R. et al. Onset and duration of action of ketotifen 0,025% and emedastine 0,05% in seasonal allergic conjunctivitis: efficacy after repeated pollen challenges in the vienna challenge chamber. Clin. Drug. Investig. 2003, v. 23 (5), p. 329-337.
  20. Borazan M., Karalezli A., Akova Y.A. et al. Efficacy of olopatadine HCI 0,1%, ketotifen fumarate 0,025%, epinastine HCI 0,05%, emedastine 0,05% and fluorometholone acetate 0,1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial Acta Ophthalmol. 2009, v. 87 (5), p. 549-554.
  21. Цывкина Е.А., Феденко Е. С. Опыт использования глазных капель «Задитен» в лечении конъюнктивитов в практике врача аллерголога. Рос. Аллергол. Журн. 2008, № 2, с. 56-59.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 1970



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies